David Turkley
Analyst, Citizens Bank
Replay available
OrthoPediatrics Corp. (NASDAQ: KIDS) Q3 2025 earnings conference call, held 2025-10-28. Replay captured from the company's public earnings webcast.

Analyst, Citizens Bank
Analyst, Lake Street Capital Markets
President and Chief Executive Officer, Orthopediatrics Corporation
Senior Managing Director, The Gilmartin Group
Chief Operating and Financial Officer, Orthopediatrics Corporation
Good afternoon and welcome to the Orthopediatrics Corporation third quarter 2025 conference call. At this time, all participants are in a listen-only mode. We will be facilitating a question and answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn the conference over to Tripp Taylor from the Gilmartin Group for a few introductory comments. Thank you for joining today's call. With me from the company are David Bailey, President and Chief Executive Officer, and Fred Height, Chief Operating and Financial Officer. Before we begin today, let me remind you that the company's remarks include forward-looking statements within the meaning of federal security laws, including the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to numerous risks and uncertainties, and the company's actual results may differ materially. For discussion of risk factors, I encourage you to review the company's most recent annual report on Form 10-K, which was filed with the SEC on March 5, 2025, and its subsequent quarterly reports on Form 10-Q. During the call today, management will also discuss certain non-GAAP financial measures, which are supplemental measures of performance. The company believes these measures provide useful information for investors in evaluating its operations period over period. For each non-GAAP financial measure referenced on this call, the company has included a reconciliation of the non-GAAP financial measure to the most directly comparable GAAP financial measure in the third quarter earnings release. Please note that the non-GAAP financial measures have limitations as analytical tools and should not be considere...